{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:46:26Z","timestamp":1794091586996,"version":"4.8.0"},"reference-count":27,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005925","name":"Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCMF-MP-110-03-01"],"award-info":[{"award-number":["TCMF-MP-110-03-01"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Urothelial dysfunction is considered a key pathological mechanism of interstitial cystitis\/bladder pain syndrome (IC\/BPS). Intravesical platelet-rich plasma (PRP) injections might be effective for treating IC\/BPS. This prospective study investigated the changes in electron microscopic findings among IC\/BPS patients after intravesical PRP injections. Twenty-six patients with refractory non-ulcer IC\/BPS underwent monthly intravesical PRP injections for 4 months. Changes in clinical symptom scores and video urodynamic study parameters were assessed from baseline to after the PRP injections. A post-treatment Global Response Assessment (GRA) score \u2265 2 was considered a successful outcome. The mean GRA score was significantly higher after 4 PRP injections than at baseline. Approximately 42% of patients experienced successful outcomes after PRP treatment. Urothelial ultrastructural defects showed no significant differences between baseline and after the PRP injections. However, patients showed variable improvements in different urothelial defects (grade improvements: urothelium cell layers, 31%; umbrella cell integrity, 42%; umbrella cell surface uroplakin plaque, 54%; tight junctions between adjacent umbrella cells, 46%; lysed organelles, 58%; inflammatory cell infiltration, 31%). Patients with successful treatment outcomes showed significant improvements in urothelial tight junction defects. Repeated intravesical PRP injections are effective for improving IC\/BPS symptoms as they promote urothelial ultrastructural defect recovery.<\/jats:p>","DOI":"10.3390\/biomedicines10051182","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T04:27:22Z","timestamp":1653020842000},"page":"1182","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Changes in the Ultrastructure of the Bladder Urothelium in Patients with Interstitial Cystitis after Intravesical Injections of Platelet-Rich Plasma"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9325-9868","authenticated-orcid":false,"given":"Yu-Khun","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Tzu Chi Medical Foundation, Buddhist Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Tzu Chi Medical Foundation, Buddhist Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Fong","family":"Jhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Tzu Chi Medical Foundation, Buddhist Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chen","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Buddhist Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-4771","authenticated-orcid":false,"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Tzu Chi Medical Foundation, Buddhist Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","article-title":"Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: An ESSIC proposal","volume":"53","author":"Nordling","year":"2008","journal-title":"Eur. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/iju.14234","article-title":"Clinical guidelines for interstitial cystitis\/bladder pain syndrome","volume":"27","author":"Homma","year":"2020","journal-title":"Int. J. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Jhang, J.F., Ho, H.C., Jiang, Y.H., Lee, C.L., Hsu, Y.H., and Kuo, H.C. (2018). Electron microscopic characteristics of interstitial cystitis\/bladder pain syndrome and their association with clinical condition. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198816"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17258","DOI":"10.1038\/s41598-021-96810-w","article-title":"Difference in electron microscopic findings among interstitial cystitis\/bladder pain syndrome with distinct clinical and cystoscopic characteristics","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"225.e13","DOI":"10.1016\/j.urology.2012.01.047","article-title":"Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis\/bladder pain syndrome","volume":"80","author":"Liu","year":"2012","journal-title":"Urology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/09537104.2016.1143922","article-title":"Cytokine, chemokine, and growth factor profile of platelet-rich plasma","volume":"27","author":"Mussano","year":"2016","journal-title":"Platelets"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12035-013-8494-7","article-title":"Platelet-rich plasma and the elimination of neuropathic pain","volume":"48","author":"Kuffler","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/nau.23898","article-title":"Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial","volume":"38","author":"Jhang","year":"2019","journal-title":"Neurourol. Urodyn."},{"key":"ref_9","first-page":"O42","article-title":"Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: A case control pilot study","volume":"11","author":"Jhang","year":"2019","journal-title":"Low Urin. Tract. Symptoms"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15218","DOI":"10.1038\/s41598-020-72292-0","article-title":"Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis","volume":"10","author":"Jiang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Jhang, J.F., Ho, H.C., Hsu, Y.H., Jiang, Y.H., and Kuo, H.C. (2022). Bladder ultrastructure and urinary cytokine abnormality in patients with recurrent urinary tract infection and the changes after intravesical platelet-rich plasma injections. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020245"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/luts.12364","article-title":"Urothelial health after platelet-rich plasma injection in intractable recurrent urinary tract infection: Improved cell proliferation, cytoskeleton, and barrier function protein expression","volume":"13","author":"Jiang","year":"2021","journal-title":"Low Urin. Tract. Symptoms"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.urology.2005.07.014","article-title":"Responsiveness of symptom scales for interstitial cystitis","volume":"67","author":"Propert","year":"2006","journal-title":"Urology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1464-410X.1983.tb03354.x","article-title":"Permeability and ultrastructure of human bladder epithelium","volume":"55","author":"Eldrup","year":"1983","journal-title":"Br. J. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0022-5347(01)67669-9","article-title":"Activation of bladder mast cells in interstitial cystitis: A light and electron microscopic study","volume":"153","author":"Theoharides","year":"1995","journal-title":"J. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2559.1984.tb02372.x","article-title":"Scanning electron microscopy of normal, neoplastic and inflamed human bladder","volume":"8","author":"Herd","year":"1984","journal-title":"Histopathology"},{"key":"ref_17","first-page":"1242","article-title":"The role of TSG-6 and uroplakin III in bladder pain syndrome\/ interstitial cystitis in rats and humans","volume":"20","author":"Lv","year":"2017","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4111\/icu.2020.61.3.304","article-title":"Changes in uroplakin expression in the urothelium of patients with ulcerative interstitial cystitis\/bladder pain syndrome","volume":"61","author":"Cho","year":"2020","journal-title":"Investig. Clin. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2003.10.041","article-title":"Critical role of mast cells in inflammatory diseases and the effect of acute stress","volume":"146","author":"Theoharides","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"ref_20","first-page":"F886","article-title":"Permeability properties of the intact mammalian bladder epithelium","volume":"271","author":"Negrete","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"F540","DOI":"10.1152\/ajprenal.2000.278.4.F540","article-title":"Urothelial pathophysiological changes in feline interstitial cystitis: A human model","volume":"278","author":"Lavelle","year":"2000","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Jiang, Y.H., Jhang, J.F., and Kuo, H.C. (2016). Revisiting the role of potassium sensitivity testing and cystoscopic hydrodistention for the diagnosis of interstitial cystitis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151692"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1464-410X.2005.05776.x","article-title":"The potassium sensitivity test: A predictor of treatment response in interstitial cystitis","volume":"96","author":"Gupta","year":"2005","journal-title":"BJU Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.5213\/inj.2142100.050","article-title":"Improved urothelial cell proliferation, cytoskeleton and barrier function protein expression in the patients with interstitial cystitis\/bladder pain syndrome after intravesical platelet-rich plasma injection","volume":"26","author":"Jhang","year":"2022","journal-title":"Int. Neurourol. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/scrt218","article-title":"Platelet-rich plasma preparation for regenerative medicine: Optimization and quantification of cytokines and growth factors","volume":"4","author":"Amable","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41598-018-19419-6","article-title":"An optimised protocol for platelet-rich plasma preparation to improve its angiogenic and regenerative properties","volume":"8","author":"Etulain","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"853776","DOI":"10.3389\/fphar.2022.853776","article-title":"Therapeutic Efficacy of intravesical platelet-rich plasma injections for interstitial cystitis\/bladder pain syndrome\u2014A comparative study of different injection number, additives and concentrations","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1182\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:15:14Z","timestamp":1760138114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["biomedicines10051182"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10051182","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]}}}